Basilea Pharmaceutica AG

BPMUF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$78$10$12-$7
Dep. & Amort.$2$2$1$1
Deferred Tax$0$0$1$2
Stock-Based Comp.$5$5$4$4
Change in WC$9-$5-$11-$33
Other Non-Cash-$19$3$0$1
Operating Cash Flow$74$14$7-$32
Investing Activities
PP&E Inv.-$2-$1-$3-$1
Net Acquisitions$1$0$0-$2
Inv. Purchases$0$0$0-$35
Inv. Sales/Matur.$0$0$95$41
Other Inv. Act.-$0-$0$0$0
Investing Cash Flow-$1-$1$92$4
Financing Activities
Debt Repay.-$16-$59$74-$23
Stock Issued$2$2$4$44
Stock Repurch.$0-$0$0-$4
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0-$124$0
Financing Cash Flow-$13-$57-$45$17
Forex Effect$0-$0$0$1
Net Chg. in Cash$60-$44$54-$11
Supplemental Information
Beg. Cash$64$109$55$66
End Cash$125$64$109$55
Free Cash Flow$73$13$4-$33